Esophageal Adenocarcinoma Methods and Protocols

185

References

1. Ashworth T (1869) A case of cancer in which
   cells similar to those in the tumours were seen
   in the blood after death. Aust Med J 14:
   146–149


2. Long L, Roberts S, Mcgrath R, Mcgrew E,
   Cole WH (1960) Cancer cells in the blood
   stream. Arch Surg 80:639–645


3. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A,
   Matera J, Miller MC, Reuben JM, Doyle GV,
   Allard WJ, Terstappen LW, Hayes DF (2004)
   Circulating tumor cells, disease progression,
   and survival in metastatic breast cancer. N Engl
   J Med 351:781–791


4. de Bono JS, Scher HI, Montgomery RB,
   Parker C, Miller MC, Tissing H, Doyle GV,
   Terstappen LW, Pienta KJ, Raghavan D (2008)
   Circulating tumor cells predict survival benefit
   from treatment in metastatic castration-
   resistant prostate cancer. Clin Cancer Res 14:
   6302–6309


5. Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
   Sabbath KD, Gabrail NY, Picus J, Morse M,
   Mitchell E, Miller MC, Doyle GV, Tissing H,
   Terstappen LW, Meropol NJ (2008)
   Relationship of circulating tumor cells to
   tumor response, progression-free survival, and
   overall survival in patients with metastatic
   colorectal cancer. J Clin Oncol 26:3213–3221


6. Huang X, Gao P, Song Y, Sun J, Chen X, Zhao
   J, Liu J, Xu H, Wang Z (2014) Relationship
   between circulating tumor cells and tumor
   response in colorectal cancer patients treated
   with chemotherapy: a meta-analysis. BMC
   Cancer 14:976


7. Georgoulias V, Bozionelou V, Agelaki S,
   Perraki M, Apostolaki S, Kallergi G, Kalbakis
   K, Xyrafas A, Mavroudis D (2012) Trastuzumab
   decreases the incidence of clinical relapses in
   patients with early breast cancer presenting
   chemotherapy-resistant CK-19mRNA-positive
   circulating tumor cells: results of a randomized
   phase II study. Ann Oncol 23:1744–1750


8. Braun S, Vogl FD, Naume B, Janni W, Osborne
   MP, Coombes RC, Schlimok G, Diel IJ, Gerber
   B, Gebauer G, Pierga JY, Marth C, Oruzio D,
   Wiedswang G, Solomayer EF, Kundt G, Strobl
   B, Fehm T, Wong GY, Bliss J, Vincent-Salomon
   A, Pantel K (2005) A pooled analysis of bone
   marrow micrometastasis in breast cancer. N
   Engl J Med 353:793–802


9. Bobek V, Matkowski R, Gürlich R, Grabowski
   K, Szelachowska J, Lischke R, Schützner J,
   Harustiak T, Pazdro A, Rzechonek A,
   Kolostova K (2014) Cultivation of circulating
   tumor cells in esophageal cancer. Folia
   Histochem Cytobiol 52:171–177
   10. Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan
   M, Yan J, Hua Y, Tiede BJ, Lu X, Haffty BG,
   Pantel K, Massagué J, Kang Y (2011) VCAM-1
   promotes osteolytic expansion of indolent
   bone micrometastasis of breast cancer by
   engaging α 4 β1-positive osteoclast progenitors.
   Cancer Cell 20:701–714
   11. Ameri K, Luong R, Zhang H, Powell AA,
   Montgomery KD, Espinosa I, Bouley DM,
   Harris AL, Jeffrey SS (2010) Circulating
   tumour cells demonstrate an altered response
   to hypoxia and an aggressive phenotype. Br
   J Cancer 102:561–569
   12. Kuhn P, Bethel K (2012) A fluid biopsy as
   investigating technology for the fluid phase of
   solid tumors. Phys Biol 9:010301
   13. Paterlini-Brechot P, Benali NL (2007)
   Circulating tumor cells (CTC) detection: clini-
   cal impact and future directions. Cancer Lett
   253:180–204
   14. Vona G, Sabile A, Louha M, Sitruk V, Romana
   S, Schütze K, Capron F, Franco D, Pazzagli M,
   Vekemans M, Lacour B, Bréchot C, Paterlini-
   Bréchot P (2000) Isolation by size of epithelial
   tumor cells : a new method for the immunomor-
   phological and molecular characterization of cir-
   culating tumor cells. Am J Pathol 156:57–63
   15. López-Novoa JM, Nieto MA (2009)
   Inflammation and EMT: an alliance towards
   organ fibrosis and cancer progression. EMBO
   Mol Med 1:303–314
   16. Reeh M, Effenberger KE, Koenig AM,
   Riethdorf S, Eichstädt D, Vettorazzi E,
   Uzunoglu FG, Vashist YK, Izbicki JR, Pantel
   K, Bockhorn M (2015) Circulating tumor cells
   as a biomarker for preoperative prognostic
   staging in patients with esophageal cancer. Ann
   Surg 261:1124–1130
   17. Driemel C, Kremling H, Schumacher S, Will
   D, Wolters J, Lindenlauf N, Mack B, Baldus
   SA, Hoya V, Pietsch JM, Panagiotidou P, Raba
   K, Vay C, Vallböhmer D, Harréus U, Knoefel
   WT, Stoecklein NH, Gires O (2014) Context-
   dependent adaption of EpCAM expression in
   early systemic esophageal cancer. Oncogene
   33:4904–4915
   18. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A,
   Anderson AE, Xiao L, Bedrosian I, Kuerer
   HM, Krishnamurthy S (2012) Circulating
   tumour cells in non-metastatic breast cancer: a
   prospective study. Lancet Oncol 13:688–695
   19. Krebs MG, Sloane R, Priest L, Lancashire L,
   Hou JM, Greystoke A, Ward TH, Ferraldeschi
   R, Hughes A, Clack G, Ranson M, Dive C,
   Blackhall FH (2011) Evaluation and prognos-
   tic significance of circulating tumor cells in

Circulating Tumour Cells